» Articles » PMID: 35107862

Chemical Characterization of Non-psychoactive Cannabis Sativa L. Extracts, in Vitro Antiproliferative Activity and Induction of Apoptosis in Chronic Myelogenous Leukaemia Cancer Cells

Overview
Journal Phytother Res
Publisher Wiley
Date 2022 Feb 2
PMID 35107862
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, extracts from non-psychoactive Cannabis sativa L. varieties were characterized by means of ultra high-performance liquid chromatography coupled with high-resolution mass spectrometry (UHPLC-HRMS) and their antiproliferative activity was assessed in vitro. The human chronic myelogenous leukaemia cell line K562 was chosen to investigate the mechanism of cell death. The effect on the cell cycle and cell death was analysed by flow cytometry. Proteins related to apoptosis were studied by western blotting. Mechanical properties of cells were assessed using the Micropipette Aspiration Technique (MAT). The results indicated that the cannabidiol (CBD)-rich extract inhibited cell proliferation of K562 cell line in a dose-dependent manner and induced apoptosis via caspase 3 and 7 activation. A significant decrease in the mitochondrial membrane potential was detected, together with the release of cytochrome c into the cytosol. The main apoptotic markers were not involved in the mechanism of cell death. The extract was also able to modify the mechanical properties of cells. Thus, this hemp extract and its pure component CBD deserve further investigation for a possible application against myeloproliferative diseases, also in association with other anticancer drugs.

Citing Articles

Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics.

Chamoso-Sanchez D, Panini M, Caroli C, Marani M, Corsi L, Ruperez F Sci Rep. 2025; 15(1):2238.

PMID: 39824876 PMC: 11742047. DOI: 10.1038/s41598-025-86044-5.


A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol.

Brighenti V, Marani M, Caroli C, Bertarini L, Gaggiotti A, Pollastro F Anal Bioanal Chem. 2024; 416(20):4555-4569.

PMID: 38940871 PMC: 11294429. DOI: 10.1007/s00216-024-05396-5.


Cannabidiol-loaded microparticles embedded in a porous hydrogel matrix for biomedical applications.

David C, de Souza J, Silva A, Grazioli G, Barboza A, Lund R J Mater Sci Mater Med. 2024; 35(1):14.

PMID: 38353746 PMC: 10866797. DOI: 10.1007/s10856-023-06773-9.


A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells.

Ceccacci S, Corsi L, Spinelli L, Caroli C, Marani M, Anceschi L Heliyon. 2024; 10(1):e24196.

PMID: 38268604 PMC: 10806336. DOI: 10.1016/j.heliyon.2024.e24196.


Chemical characterization of non-psychoactive Cannabis sativa L. extracts, in vitro antiproliferative activity and induction of apoptosis in chronic myelogenous leukaemia cancer cells.

Anceschi L, Codeluppi A, Brighenti V, Tassinari R, Taglioli V, Marchetti L Phytother Res. 2022; 36(2):914-927.

PMID: 35107862 PMC: 9304126. DOI: 10.1002/ptr.7357.

References
1.
Appendino G, Chianese G, Taglialatela-Scafati O . Cannabinoids: occurrence and medicinal chemistry. Curr Med Chem. 2011; 18(7):1085-99. DOI: 10.2174/092986711794940888. View

2.
Olivas-Aguirre M, Torres-Lopez L, Valle-Reyes J, Hernandez-Cruz A, Pottosin I, Dobrovinskaya O . Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia. Cell Death Dis. 2019; 10(10):779. PMC: 6791884. DOI: 10.1038/s41419-019-2024-0. View

3.
Aliferis K, Bernard-Perron D . Cannabinomics: Application of Metabolomics in ( L.) Research and Development. Front Plant Sci. 2020; 11:554. PMC: 7225349. DOI: 10.3389/fpls.2020.00554. View

4.
Gottlieb E, Armour S, Harris M, Thompson C . Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 2003; 10(6):709-17. DOI: 10.1038/sj.cdd.4401231. View

5.
Dagenais G, Leong D, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R . Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2019; 395(10226):785-794. DOI: 10.1016/S0140-6736(19)32007-0. View